NuvaRing

PreclinicalSmall molecule

UUniversity of Washington

NuvaRing is one of 111 small molecule programs targeting Contraception. It is currently in Preclinical.

Indications

Total Trials

Active Trials

110

Competitors

Pipeline

Status by Indication[3][1]

Indication

ContraceptionActive, not recruiting

MenorrhagiaActive, not recruiting

OvarianCompleted

TreatmentTerminated

AdolescentTerminated

AcceptabilityCompleted

ContraceptionPreclinical

Active, not recruiting

MenorrhagiaPreclinical

Active, not recruiting

OvarianPreclinical

Completed

TreatmentPreclinical

Terminated

AdolescentPreclinical

Terminated

AcceptabilityPreclinical

Completed

Competition

Competitive Landscape

350 competitors in Treatment

#DrugCompanyPhaseTrials

Dexilant

Takeda

Preclinical

2 2

Minipress

Pfizer

Preclinical

1 3

Lamprene

Novartis

Preclinical

1 4

Emtriva

Gilead

Preclinical

1 5

Foscavir

CClinigen, Inc.

Preclinical

6 6

Hivid

CConrado Roberto Hoffmann Filho

Preclinical

6 7

Valium

Akero Therapeutics

Preclinical

2 8

Lotemax

PPharmos

Preclinical

1 9

Norpramin

VValidus Pharmaceuticals

Preclinical

1 10

Barhemsys

Tibotec Pharmaceuticals, Ireland

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Microbiota2 trials

Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity

Completed·UUniversity of Washington·Phase 4·NCT02445989·120 enrolled

Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity

Completed·UUniversity of Washington·Phase 4·NCT02432404·81 enrolled

Contraception2 trials

Psychosocial and Physiological Mechanisms in the Effect of Hormonal Contraception on the Female Sexual Desire

Completed·UUniversity Hospital, Ghent·N/A·NCT00374387·150 enrolled

Hormonal Contraception and Vaginal Health

Completed·OOregon Health and Science University·N/A·NCT00612508·14 enrolled

Obese1 trial

Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®

Completed·—·N/A·NCT00710606·40 enrolled

Treatment1 trial

NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment

Terminated·UUniversity of Toronto·N/A·NCT01298128·70 enrolled

Acceptability1 trial

Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya

Completed·CCenters for Disease Control and Prevention·N/A·NCT02529683·200 enrolled

4 more indications

Female1 trial

A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)

Completed·OOrganon and Co·Phase 4·NCT01044056·24 enrolled

Ovarian1 trial

Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women

Completed·UUniversity of Saskatchewan·N/A·NCT00565240·41 enrolled

Menorrhagia1 trial

Efficacy of Combined Contraceptive Vaginal Ring(NuvaRing)in Women With Idiopathic Menorrhagia

Completed·MMansoura University·N/A·NCT01266759·95 enrolled

Adolescent1 trial

Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents

Terminated·VVirginia Commonwealth University·N/A·NCT00369967·48 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for NuvaRing. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — NuvaRing compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for NuvaRing. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Washington company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Washington

NuvaRing

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Microbiota2 trials

Contraception2 trials

Obese1 trial

Treatment1 trial

Acceptability1 trial

Female1 trial

Ovarian1 trial

Menorrhagia1 trial

Adolescent1 trial

References

Drug Info

Quick Facts

Related News